MJBizDaily
How to get a cannabis business permit in Virginia – and what regulators still need to sort out
Featured
Latest Posts
Philadelphia medical marijuana research center in flux
A Philadelphia research center that initially was expected to provide an economic boost to the medical cannabis industry faces an uncertain future.
News July 29
Arizona attorney general OKs digital medical cannabis payments
Arizona Attorney General Mark Brnovich approved a trial program allowing digital payments to medical marijuana dispensaries, a move that could significantly influence the way the state’s unbanked MMJ firms transact business…
News July 29Cresco rebranding medical marijuana dispensaries to Sunnyside
Chicago-based Cresco Labs will rebrand its medical cannabis dispensaries under the name Sunnyside, a move designed to put personal wellness at the center of its sales pitch.
News July 29
New normal in US Congress: Marijuana hearings, reform bills & how they could affect the MJ industry
Cannabis has gone from the butt of jokes on Capitol Hill to milestone hearings and the introduction of landmark legalization reform packages that offer the potential to pave the way…
News July 29
Opportunities continue to multiply for US cannabis companies seeking to raise capital
The American marijuana industry is in a far better place for businesses seeking to raise money than it was a year ago. In fact, the landscape has grown leaps and…
News July 27
British tobacco giant invests CA$123 million in Canadian cannabis firm Auxly
Imperial Brands said it will invest 123 million Canadian dollars ($93.4 million) in a British Columbia cannabis company, the United Kingdom tobacco giant’s latest foray into the marijuana industry. With…
News July 26
California marijuana track-and-trace data to remain confidential
The vast majority of California’s data from its cannabis track-and-trace system will be kept out of the public domain, according to a top state regulator. That may surprise or disappoint…
News July 26
GW Pharma’s cannabis drug OK’d by European Medicines Agency panel
GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines…
News July 26
Canadian bank’s ‘unfair’ cannabis fees add to financial hurdles for lottery hopefuls
One of Canada’s top lenders is charging prospective cannabis business owners thousands of dollars for a routine review of financial documents, imposing an added cost on entrepreneurs who want to…
News July 26
Latest Sponsored
